-
Characterization of influenza A virus pseudotyped with the spike protein of porcine epidemic diarrhea virus
- Back
Metadata
Document Title
Characterization of influenza A virus pseudotyped with the spike protein of porcine epidemic diarrhea virus
Author
Wanitchang A, Saenboonrueng J, Srisutthisamphan K, Jongkaewwattana A
Name from Authors Collection
Scopus Author ID
25824516500
Scopus Author ID
6508363658
Scopus Author ID
57003681700
Affiliations
National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)
Type
Article
Source Title
ARCHIVES OF VIROLOGY
ISSN
0304-8608
Year
2018
Volume
163
Issue
4
Open Access
Green Published, Bronze
Publisher
SPRINGER WIEN
DOI
10.1007/s00705-018-4001-9
Format
Abstract
The coronavirus spike protein and the influenza virus hemagglutinin are class I viral membrane fusion proteins. While the two proteins display strong structural conservation and the mechanisms underlying membrane fusion are similar, they share no sequence similarity. Whether they are functionally interchangeable is currently unknown. In this study, we constructedscIAV-S, asingle-cycle influenza A virus pseudotyped with the spike protein of porcine epidemic diarrhea virus (PEDV), and demonstrated that this virus could infect cultured cells and trigger massive syncytium formation. Treatment with endocytosis inhibitors did not affect syncytium formation by infected cells. Moreover, the infectivity of scIAV-S was associated with the degree of cell adaptation of PEDV-S. Intriguingly, scIAV-S lacking functional neuraminidase (NA) exhibited substantially higher infectivity, suggesting a pivotal role of the sialic acid in the binding/entry of PEDV. Together, scIAV-S offers a robust platform for the investigation of the entry mechanism of PEDV or, possibly, of other coronaviruses.
Funding Sponsor
National Center for Genetic Engineering and Biotechnology (BIOTEC)'s Fellow Grant; National Science and Technology Development Agency [P-15-51261]; Giga Impact Initiative Grant [P16-51674]
License
Copyright
Rights
Springer-Verlag GmbH Austria, part of Springer Nature
Publication Source
WOS